Drawing for INVIOS

USPTO serial 79355607

INVIOS

Reviewed by CopyMark Law Group

Reg. 8026380Status 700Registered
Filing date
Status date
Registration date
Nov 18, 2025
Examiner
CLYBURN, CARLA DIONNE
Law office
PETITIONS OFFICE

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with INVIOS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael J. Leonard

Michael J. Leonard Fox Rothschild LLP997 Lenox Drive, Bldg. 3Lawrenceville, NJ 08648-2311United States

Goods and services

ClassDescriptionStatusFirst use
001Chemical, biochemical and biotechnological preparations used in industry and scienceACTIVE—
005Pharmaceutical and veterinary pharmaceutical preparations and substances for treatment of cancer, regulating the immune system, treatment of immune system diseases and disorders, and for cell therapy; diagnostic preparations for medical purposes in the nature of treatment of cancer, regulating the immune system, treatment of immune system diseases and disorders, and for cell therapy; biopharmaceutical, biological and chemical preparations and substances for medical use in the nature of treatment of cancer, regulating the immune system, treatment of immune system diseases and disorders, and for cell therapy; pharmaceutical and veterinary pharmaceutical preparations and substances for the treatment of cancer, regulation of the immune system, treatment of diseases of the immune system and cell therapyACTIVE—
010Surgical and veterinary apparatus and instruments for the treatment and prevention of cancer, for the regulation of the immune system, for the treatment of diseases of the immune system, for cell therapy; medical diagnostic apparatus for testing blood cells, cancer cells and immune cells as therapeutic agents and modifications thereof; medical apparatus and instruments for the treatment and prevention of cancer, for the regulation of the immune system, for the treatment of diseases of the immune system, for cell therapy; medical apparatus and instruments for preparing and processing blood and other cell preparations for medical purposes in the nature of cancer treatment, regulation of the immune system and treatment of diseases of the immune system and cell therapy; medical apparatus and instruments for cell therapy; parts for the aforesaid goods, included in this class and only for purposes before mentionedACTIVE—
042Surgical and veterinary apparatus and instruments for the treatment and prevention of cancer, for the regulation of the immune system, for the treatment of diseases of the immune system, for cell therapy; medical diagnostic apparatus for testing blood cells, cancer cells and immune cells as therapeutic agents and modifications thereof; medical apparatus and instruments for the treatment and prevention of cancer, for the regulation of the immune system, for the treatment of diseases of the immune system, for cell therapy; medical apparatus and instruments for preparing and processing blood and other cell preparations for medical purposes in the nature of cancer treatment, regulation of the immune system and treatment of diseases of the immune system and cell therapy; medical apparatus and instruments for cell therapy; parts for the aforesaid goods, included in this class and only for purposes before mentioned.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 18, 2026FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
May 30, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB—
May 30, 2026FIMPFINAL DISPOSITION PROCESSED—
Feb 18, 2026FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Nov 18, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Nov 18, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 19, 2024ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
May 7, 2024OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Apr 22, 2024CHPBPOST PUBLICATION AMENDMENT - ENTERED—
Apr 22, 2024APETASSIGNED TO PETITION STAFF—
Apr 17, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 17, 2024OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Mar 13, 2024EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Feb 5, 2024ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Jan 9, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 9, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 8, 2024GPNXNOTIFICATION PROCESSED BY IB—
Dec 20, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 20, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Dec 20, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 29, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 29, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 28, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 28, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 4, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jun 26, 2023RFNTREFUSAL PROCESSED BY IB—
Jun 5, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 5, 2023RFRRREFUSAL PROCESSED BY MPU—
Apr 7, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 6, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 31, 2023DOCKASSIGNED TO EXAMINER—
Nov 22, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 18, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 17, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance